HealthTechMovers.com has identified several healthtech stocks which are expected to go “Ex-Dividend” very soon. Remember, if you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment. Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
DividendPress.com is following several dividend stocks including MPW, BANF, AVGO and more.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
So please keep this in mind.
Below is our latest Dividend Report:
Sienna Senior Living
Symbol: LWSCF
Recent LWSCF Price: $10.10
Average Analyst Price Target: $13.09 (29.71%)
LWSCF Market Cap: $742.13M
Expected Ex-Dividend Date for LWSCF stock: Jun 29 2022
Expected Payment Date for LWSCF stock: Jul 15 2022
Expected Dividend & Yield for LWSCF stock: 7.13%
Recent Analyst Action: Tal Woolley, analyst at National Bank, reiterates coverage on Sienna Senior Living (LWSCF) stock in the Healthcare sector with a Buy rating and a price target of $ 13.58 (1 month ago).
Click for full story >>--------------------------------------------------------------------------
Stryker
Symbol: SYK
Recent SYK Price: $204.43
Average Analyst Price Target: $279.82 (36.88%)
SYK Market Cap: $77.31B
Expected Ex-Dividend Date for SYK stock: Jun 29 2022
Expected Payment Date for SYK stock: Jul 29 2022
Expected Dividend & Yield for SYK stock: 1.30%
Recent Analyst Action: David Turkaly, analyst at JMP Securities, reiterates coverage on Stryker (SYK) stock in the Healthcare sector with a Hold rating and a price target of n/a (2 weeks ago).
Click for full story >>--------------------------------------------------------------------------
Bristol Myers
Symbol: BMY
Recent BMY Price: $78.96
Average Analyst Price Target: $78.17 (-1.00%)
BMY Market Cap: $168.11B
Expected Ex-Dividend Date for BMY stock: Jun 30 2022
Expected Payment Date for BMY stock: Aug 01 2022
Expected Dividend & Yield for BMY stock: 2.61%
Recent Analyst Action: Evan Seigerman, analyst at BMO Capital, reiterates coverage on Bristol Myers (BMY) stock in the Healthcare sector with a Buy rating and a price target of $ 92 (2 weeks ago).
Click for full story >>--------------------------------------------------------------------------
DividendPress.com helps you find the best performing dividend stocks. We alert our subscribers of coming ex-dividend dates.